You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

erythropoiesis-stimulating agents (ESA)

Showing 1 - 25 of 7,131
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

End Stage Renal Disease Trial in Kaohsiung (AI (model))

Completed
  • End Stage Renal Disease
  • AI (model)
  • Kaohsiung, TW, Taiwan
    Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
Aug 31, 2021

Anemia, Cancer Trial (Ferric carboxymaltose (FCM))

Completed
Has Results
  • Anemia
  • Cancer
  • Ferric carboxymaltose (FCM)
  • (no location specified)
Dec 8, 2021

End Stage Renal Disease on Dialysis Trial in Kaohsiung, (novel artificial intelligence assisted platform)

Recruiting
  • End Stage Renal Disease on Dialysis
  • novel artificial intelligence assisted platform
  • Kaohsiung,, Taiwan
    Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH)
Oct 5, 2021

MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • Sodium Valproate, Bezafibrate, Medroxyprogesterone
  • Danazol
  • Dudley, England, United Kingdom
  • +7 more
Aug 12, 2022

Erythropoiesis Stimulating Agents for Anemia Management in

Completed
  • Anemia of Chronic Kidney Disease
  • +2 more
    • Giza, Egypt
      the Memorial Souad Kafafi University Hospital
    Jan 24, 2023

    Erythropoiesis Stimulating Agents Hyporesponsiveness in Dialysis

    Not yet recruiting
    • Erythropoietin Resistant Anemia (EPO Resistant Anemia)
      • (no location specified)
      Sep 22, 2023

      Anemia of Chronic Kidney Disease Trial in Hackensack (Vadadustat)

      Suspended
      • Anemia of Chronic Kidney Disease
      • Hackensack, New Jersey
        Research Site
      Aug 23, 2022

      MDS Trial in Tampa (Canakinumab Injection, Darbepoetin Alfa)

      Recruiting
      • Myelodysplastic Syndromes
      • Canakinumab Injection
      • Darbepoetin Alfa
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 21, 2022

      Anemia Trial in Anyang-si (Ferric Derisomaltose Injection, Darbepoetin Alfa Injection)

      Recruiting
      • Anemia
      • Ferric Derisomaltose Injection
      • Darbepoetin Alfa Injection
      • Anyang-si, Korea, Republic of
        Hallym University Medical Center
      Mar 13, 2023

      MDS Trial in Worldwide (Talacotuzumab, Daratumumab)

      Completed
      Has Results
      • Myelodysplastic Syndromes
      • Saint Louis, Missouri
      • +20 more
      Dec 28, 2022

      Anemia in Dialysis-dependent CKD Patients Trial in Alexandria (Roxadustat)

      Recruiting
      • Anemia in Dialysis-dependent CKD Patients
      • Alexandria, Egypt
        Alexandria University
      Oct 29, 2023

      MDS Trial (Imetelstat)

      Available
      • Myelodysplastic Syndromes
      • (no location specified)
      Jun 30, 2023

      Anemia Trial in Worldwide (Vadadustat, Darbepoetin alfa)

      Completed
      • Anemia
      • Chula Vista, California
      • +58 more
      Nov 10, 2022

      Anemia, Sickle Cell, Sickle Cell Disease Trial in Pittsburgh, Lagos (Hydroxyurea, Epoetin Alfa)

      Not yet recruiting
      • Anemia, Sickle Cell
      • Sickle Cell Disease
      • Pittsburgh, Pennsylvania
      • +1 more
      Aug 4, 2022

      Hyperphosphatemia, Anemia, Iron Deficiency, Renal Insufficiency Trial in United States (Ferric Citrate 1 gram Oral Tablet,

      Completed
      • Hyperphosphatemia
      • +2 more
      • Ferric Citrate 1 gram Oral Tablet
      • Standard of care phosphate-lowering therapy
      • Anchorage, Alaska
      • +12 more
      Nov 3, 2022

      Anemia Trial in Palma de Mallorca (Paricalcitol, Epoetin beta, Placebo)

      Recruiting
      • Anemia
      • Palma de Mallorca, Islas Baleares, Spain
        Son Espases University Hospital
      Mar 3, 2021

      Anemia, Dialysis-Dependent Chronic Kidney Disease Trial in United States (vadadustat, epoetin alfa)

      Terminated
      Has Results
      • Anemia
      • Dialysis-Dependent Chronic Kidney Disease
      • Bakersfield, California
      • +17 more
      Feb 2, 2021

      MDS, Anemia Trial in Germany (Luspatercept Injection)

      Recruiting
      • Myelodysplastic Syndromes
      • Anemia
      • Luspatercept Injection
      • Berlin, Germany
      • +18 more
      Jan 25, 2023

      MDS Trial in Worldwide (Luspatercept)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Los Alamitos, California
      • +53 more
      Sep 13, 2023

      MDS Trial in Beijing (Roxadustat, Luspatercept)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Beijing, China
        Peking union medical college hospital
      Aug 17, 2023

      Chronic Kidney Disease Hyporesponsive Anemia to Erythropoiesis

      Completed
      • Renal Anemia
      • Chronic Kidney Disease
        • Niigata, Japan
          Niigata University Graduate School of Medicine
        Jun 17, 2020

        End Stage Renal Disease (ESRD) Trial in Poitiers (Hemodialysis sessions using SHFVE dialyzer (VieX™) or the MCO (Theranova 500™)

        Not yet recruiting
        • End Stage Renal Disease (ESRD)
        • Hemodialysis sessions using SHFVE dialyzer (VieX™) or the MCO (Theranova 500™) dialyzer
        • Poitiers, France
          CHU de Poitiers
        Jan 12, 2023

        Hyperphosphatemia Trial in Los Angeles (Ferric Citrate)

        Completed
        Has Results
        • Hyperphosphatemia
        • Ferric Citrate
        • Los Angeles, California
          Kaiser Permanente Los Angeles Medical Center
        Jan 3, 2022

        Chronic Kidney Disease Trial in Japan (roxadustat)

        Completed
        • Chronic Kidney Disease
        • Aichi, Japan
        • +37 more
        Apr 8, 2021

        Dialysis Trial in Murray (Algorithm model-based Aranesp doses, Standard of care)

        Not yet recruiting
        • Dialysis
        • Algorithm model-based Aranesp doses
        • Standard of care
        • Murray, Utah
        • +1 more
        Jun 27, 2023